Helsinn Therapeutics (U.S.) Inc. becomes the exclusive distributor of ALOXI® (palonosetron HCI) in the U.S.

Iselin, NJ, USA, June 28, 2018 – Helsinn Therapeutics...

Helsinn Group and Angelini support Satellite Symposium at MASCC/ISOO 2018 Annual Meeting

Leading cancer supportive care experts in oncology explore how...

38th Ordinary General Meeting of Farma Industria Ticino

The 2018 Ordinary General Meeting of Farma Industria Ticino...